Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

The Supreme Court's Regeneron Pharmaceuticals Inc v Kymab Ltd decision to revoke two patents for transgenic mouse technology has caused concern to biotech patent owners, especially since the Supreme Court expressed a need to rebalance patent law.


Dates Thursday, July 23, 2020 - Download as vCalendar
Event Times: 16:00 to 17:00
Venue Online
Website Event website

Event details:

Has this case shifted the boundaries of patent protection, or merely clarified the status quo? What is its context, and broader impact on patents both within and outside the life sciences technology area?

Our experts will explain the case and answer these questions in this webinar.


Taylor Wessing is a full-service international law firm, working with clients in the world’s most dynamic industries. We take a single-minded approach to advising our clients, helping them succeed by thinking innovatively about their business issues. We support clients wherever they want to do business. The firm has a sector focus with experts in technology, media and communications, life sciences and private